Results 191 to 200 of about 28,512 (352)

Perioperative Piperacillin/Tazobactam Reduces Early Onset SSI in Preirradiated Patients Undergoing Microvascular Head and Neck Reconstruction

Head &Neck, EarlyView.
ABSTRACT Background Preirradiated patients undergoing microvascular head and neck reconstruction for tumor recurrence or osteoradionecrosis (ORN) face surgical site infection (SSI) rates exceeding 30%. The impact of perioperative extended‐spectrum antibiotic coverage remains unclear. This study hypothesizes that calculated prophylaxis with piperacillin/
Johannes G. Schuderer, Florian Hoferer, Jonas Eichberger, Mathias Fiedler, André Gessner, Stilla Bauernfeind, Maximilian Gottsauner, Felix Nieberle, Michael Maurer, Johannes K. Meier, Torsten E. Reichert, Tobias Ettl   +11 more
wiley   +1 more source

Drug-Induced Bullous Pemphigoid Triggered by Immune Checkpoint Inhibitor Opdualag in an Elderly Patient With Recurrent Metastatic Melanoma: A Case Report and Treatment Course With Dupilumab. [PDF]

Cureus
Moreno BA, Lutwak M, Lutwak D, Kerdel F.
europepmc   +1 more source

Systemic Absorption and Pharmacokinetics of Five Novel Topical Dermatologic Agents: A Review

Mary Dyson, Kara Hurley, Hannah Chaudhury, Lara Shehadeh, Cameron West   +4 more
openalex   +1 more source

The management of antithrombotic medications, prothrombin time-international normalized ratio, and bleeding complications in patients taking antithrombotic agents during dermatological surgery

, 2015
Tetsuo SHUKUWA, Hiroshi Ishikawa
openalex   +1 more source

The rise of Chemical Peeling in 19th‐century European Dermatology: emergence of agents, formulations and treatments [PDF]

, 2020
Claudia Borelli, Frank Ursin, Florian Steger   +2 more
openalex   +1 more source

High Resolution Ultrasound for the Assessment of Melasma: Experience With 1064 nm Q-Switched Nd:YAG Laser. [PDF]

Cureus
Trujillo Ramírez L, Meza Corso MF, Gonzalez C, Amador JR, Holguín A, González C.   +5 more
europepmc   +1 more source

Optimizing the integration of modern systemic therapies and advanced radiotherapy techniques in breast cancer management: An expert opinion from the Institut Curie Breast Radiotherapy Group

International Journal of Cancer, EarlyView.
Abstract The integration of modern systemic therapies with radiotherapy (RT) represents a promising strategy in breast cancer management, enhancing both locoregional control and systemic disease outcomes. This expert consensus from the Institut Curie Breast Radiotherapy Group focuses exclusively on modern systemic agents, synthesizing current evidence ...
Cezara Cheptea, Pierre Loap, Sofiane Allali, Alain Fourquet, Kim Cao, Youlia Kirova   +5 more
wiley   +1 more source

Delivering precision oncology in metastatic breast cancer: Clinical impact of comprehensive genomic profiling—The CATCH experience

International Journal of Cancer, EarlyView.
What's New? CATCH is a prospective precision oncology registry trial that harnesses whole‐genome/exome‐ and RNA‐sequencing to enable actionable biomarker detection in metastatic breast cancer patients of any subtype. The data of the first 412 consecutive patients with completed follow‐up in this real‐world, single‐center patient cohort provide robust ...
Mario Hlevnjak, Sabine Heublein, Verena Thewes, Lukas Wagener, Constantin Pixberg, Carlo Fremd, Laura Michel, Christian Maurer, Lars Buschhorn, Nicola Dikow, Fangyoumin Feng, Stefan Fröhling, Christel Herold‐Mende, Steffen Hirsch, Chen Hong, Daniel Hübschmann, Lena Jassowicz, Polina Kozyulina, Katrin Pfütze, Richard F. Schlenk, Hans‐Peter Sinn, Katharina Smetanay, Christoph Springfeld, Albrecht Stenzinger, Celina Wagner, Stephan Wolf, Andreas Trumpp, Dirk Jäger, Oliver Zivanovic, Marc Zapatka, Andreas Schneeweiss, Peter Lichter   +31 more
wiley   +1 more source

Oral side effects of dermatologic therapies: A systematic review and meta-analysis. [PDF]

Bioinformation
M Alqahtani R, Ahmad Farhan MA, M Almutiari S, Fajr Ehab AA, Abdulmohsen Abdulkarim FA, Zwiri A, Sghaireen MG, Alam MK.   +7 more
europepmc   +1 more source

[Topical antimicrobial agents in dermatology].

Actas dermo-sifiliograficas, 2010
Topical antimicrobial agents are chemical substances that, directly applied to the skin, inhibit the growth or destroy any microorganism, either fungi, viruses or bacteria. Within this term, we generally refer to those that are active against the latter. They are divided into antiseptics and antibiotics.
openaire   +1 more source